analytics_image
Access TOC - Nuclear Medicine Market 2025\
Vantage Market Research
Vantage Market Research

Reports - Nuclear Medicine Market

iconHealthcare

Nuclear Medicine Market

Nuclear Medicine Market Valuation and Growth Forecast 2025-2035 by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes) by Applications (Diagnostic Applications, Procedural Volume Assessment, Diagnostic Procedures, Therapeutic Procedures) by Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Table of Contents

Chapter 1   Executive Dashboard
1. Strategic Imperatives
Chapter 2   Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3   Global Nuclear Medicine Market - Segment Analysis
1. Overview
2. Global Nuclear Medicine Market, 2021 - 2035 (USD Million)
3. Global Nuclear Medicine Market - by Type
3.1. By Diagnostic Nuclear Medicine
3.2. By Therapeutic Nuclear Medicine
3.3. By Brachytherapy Isotopes
4. Global Nuclear Medicine Market - by Applications
4.1. By Diagnostic Applications
4.2. By Procedural Volume Assessment
4.3. By Diagnostic Procedures
4.4. By Therapeutic Procedures
5. Global Nuclear Medicine Market - by Procedural Volume Assessment
5.1. By Diagnostic Procedures
5.2. By Therapeutic Procedures
6. Global Nuclear Medicine Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4   North America Nuclear Medicine Market - Segment Analysis
1. Overview
2. North America Nuclear Medicine Market, 2021 - 2035 (USD Million)
3. North America Nuclear Medicine Market - by Type
3.1. By Diagnostic Nuclear Medicine
3.2. By Therapeutic Nuclear Medicine
3.3. By Brachytherapy Isotopes
4. North America Nuclear Medicine Market - by Applications
4.1. By Diagnostic Applications
4.2. By Procedural Volume Assessment
4.3. By Diagnostic Procedures
4.4. By Therapeutic Procedures
5. North America Nuclear Medicine Market - by Procedural Volume Assessment
5.1. By Diagnostic Procedures
5.2. By Therapeutic Procedures
Chapter 5   Europe Nuclear Medicine Market - Segment Analysis
1. Overview
2. Europe Nuclear Medicine Market, 2021 - 2035 (USD Million)
3. Europe Nuclear Medicine Market - by Type
3.1. By Diagnostic Nuclear Medicine
3.2. By Therapeutic Nuclear Medicine
3.3. By Brachytherapy Isotopes
4. Europe Nuclear Medicine Market - by Applications
4.1. By Diagnostic Applications
4.2. By Procedural Volume Assessment
4.3. By Diagnostic Procedures
4.4. By Therapeutic Procedures
5. Europe Nuclear Medicine Market - by Procedural Volume Assessment
5.1. By Diagnostic Procedures
5.2. By Therapeutic Procedures
Chapter 6   Asia Pacific Nuclear Medicine Market - Segment Analysis
1. Overview
2. Asia Pacific Nuclear Medicine Market, 2021 - 2035 (USD Million)
3. Asia Pacific Nuclear Medicine Market - by Type
3.1. By Diagnostic Nuclear Medicine
3.2. By Therapeutic Nuclear Medicine
3.3. By Brachytherapy Isotopes
4. Asia Pacific Nuclear Medicine Market - by Applications
4.1. By Diagnostic Applications
4.2. By Procedural Volume Assessment
4.3. By Diagnostic Procedures
4.4. By Therapeutic Procedures
5. Asia Pacific Nuclear Medicine Market - by Procedural Volume Assessment
5.1. By Diagnostic Procedures
5.2. By Therapeutic Procedures
Chapter 7   Latin America Nuclear Medicine Market - Segment Analysis
1. Overview
2. Latin America Nuclear Medicine Market, 2021 - 2035 (USD Million)
3. Latin America Nuclear Medicine Market - by Type
3.1. By Diagnostic Nuclear Medicine
3.2. By Therapeutic Nuclear Medicine
3.3. By Brachytherapy Isotopes
4. Latin America Nuclear Medicine Market - by Applications
4.1. By Diagnostic Applications
4.2. By Procedural Volume Assessment
4.3. By Diagnostic Procedures
4.4. By Therapeutic Procedures
5. Latin America Nuclear Medicine Market - by Procedural Volume Assessment
5.1. By Diagnostic Procedures
5.2. By Therapeutic Procedures
Chapter 8   Middle East & Africa Nuclear Medicine Market - Segment Analysis
1. Overview
2. Middle East & Africa Nuclear Medicine Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Nuclear Medicine Market - by Type
3.1. By Diagnostic Nuclear Medicine
3.2. By Therapeutic Nuclear Medicine
3.3. By Brachytherapy Isotopes
4. Middle East & Africa Nuclear Medicine Market - by Applications
4.1. By Diagnostic Applications
4.2. By Procedural Volume Assessment
4.3. By Diagnostic Procedures
4.4. By Therapeutic Procedures
5. Middle East & Africa Nuclear Medicine Market - by Procedural Volume Assessment
5.1. By Diagnostic Procedures
5.2. By Therapeutic Procedures
Chapter 9   Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10   COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11   Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12   Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13   Company Profiles
1. Curium
2. Bracco Imaging S.P.A.
3. Pharmalogic
4. Eczacibaşi-Monrol Nuclear Products
5. Cardinal Health
6. NTP Radioisotopes SOC LTD. (A Subsidiary of South African Nuclear Energy Corporation)
7. GE Healthcare
8. Nordion Inc. (A Sotera Health Company)
9. Advanced Accelerator Applications (AAA) (A part of Novartis)
10. Northstar Medical Radioisotopes LLC
11. Eckert & Ziegler
12. Joint Stock Company Isotope (JSC Isotope)
13. Bayer AG
14. Siemens Healthineers
15. Jubilant Draximage Inc. (A Subsidiary of Jubilant Pharma)
16. Lantheus Medical Imaging Inc.
17. Global Medical Solutions
18. Shine Medical Technologies
19. Isotopia Molecular Imaging Ltd.
20. Sinotau Pharmaceutical Group
21. Institute of Isotopes Co. Ltd.
22. China Isotope & Radiation Corporation
23. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
24. Cyclopharm
25. IRE Elit
Chapter 14   Key Primary Respondents - VERBATIM
Chapter 15   Discussion Guide
Chapter 16   Customization Offered
Chapter 17   Annexure
Chapter 18   List of Figures
Chapter 19   List of Tables
Chapter 20   List of Abbreviations

FAQ‘s

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by